Taiwan FDA registration 374ec6194e276cf7d0081f0f4b182cdf
KatiaTM thyroglobulin antibody test set
TW: 卡蒂雅TM甲狀腺球蛋白抗體檢測試劑組
Taiwan·Risk Class 2·TRINITY BIOTECH USA·Registered Aug 10, 2006 – Aug 10, 2011CancelledRegistration details
- Analysis ID
- 374ec6194e276cf7d0081f0f4b182cdf
- Customs Code
- DHA00601727300
Company information
- Manufacturer
- TRINITY BIOTECH USA
- Manufacturer Country
- United States
- Authorized Representative
- GRAND MARQUIS CO., LTD.
Product details
- Intended Use
- Enzyme immunoadsorption assay was used to detect thyroglobulin antibody in human serum.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1685 Thyroxine-binding globulin testing system
- Import Information
- import
Dates and status
- Registration Date
- Aug 10, 2006
- Expiry Date
- Aug 10, 2011
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for KatiaTM thyroglobulin antibody test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 374ec6194e276cf7d0081f0f4b182cdf and manufactured by TRINITY BIOTECH USA. The authorized representative in Taiwan is GRAND MARQUIS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices